skip to main content
Idioma:
Refinado por: assunto: Cancer remover Annals Of Oncology remover assunto: Oncology remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Origins of socio-economic inequalities in cancer survival: a review
Origins of socio-economic inequalities in cancer survival: a review
Material Type:
Artigo 		Adicionar ao Meu Espaço

Origins of socio-economic inequalities in cancer survival: a review

Woods, L. M. ; Rachet, B. ; Coleman, M. P.

Annals of oncology, 2006-01, Vol.17 (1), p.5-19 [Periódico revisado por pares]

Oxford: Oxford University Press

Texto completo disponível

Citações Citado por
2
Cancer prevalence in European registry areas
Cancer prevalence in European registry areas
Material Type:
Artigo 		Adicionar ao Meu Espaço

Cancer prevalence in European registry areas

Micheli, A. ; Mugno, E. ; Krogh, V. ; Quinn, M. J. ; Coleman, M. ; Hakulinen, T. ; Gatta, G. ; Berrino, F. ; Capocaccia, R. ; the EUROPREVAL Working Group

Annals of oncology, 2002-06, Vol.13 (6), p.840-865 [Periódico revisado por pares]

Oxford: Oxford University Press

Texto completo disponível

Citações Citado por
3
Prognoses for head and neck cancers in Europe diagnosed in 1995–1999: a population-based study
Prognoses for head and neck cancers in Europe diagnosed in 1995–1999: a population-based study
Material Type:
Artigo 		Adicionar ao Meu Espaço

Prognoses for head and neck cancers in Europe diagnosed in 1995–1999: a population-based study

Zigon, G. ; Berrino, F. ; Gatta, G. ; Sánchez, M.-J. ; van Dijk, B. ; Van Eycken, E. ; Francisci, S.

Annals of oncology, 2011-01, Vol.22 (1), p.165-174 [Periódico revisado por pares]

Oxford: Elsevier Ltd

Texto completo disponível

Citações Citado por
4
A comparative analysis of cancer prevalence in cancer registry areas of France, Italy and Spain
A comparative analysis of cancer prevalence in cancer registry areas of France, Italy and Spain
Material Type:
Artigo 		Adicionar ao Meu Espaço

A comparative analysis of cancer prevalence in cancer registry areas of France, Italy and Spain

Verdecchia, A. ; Micheli, A. ; Colonna, M. ; Moreno, V. ; Izarzugaza, M. I. ; Paci, E.

Annals of oncology, 2002-07, Vol.13 (7), p.1128-1139 [Periódico revisado por pares]

Oxford: Oxford University Press

Texto completo disponível

Citações Citado por
5
Cancer prevalence in Northern Europe: the EUROPREVAL study
Cancer prevalence in Northern Europe: the EUROPREVAL study
Material Type:
Artigo 		Adicionar ao Meu Espaço

Cancer prevalence in Northern Europe: the EUROPREVAL study

Möller, T. ; Anderson, H. ; Aareleid, T. ; Hakulinen, T. ; Storm, H. ; Tryggvadottir, L. ; Corazziari, I. ; Mugno, E.

Annals of oncology, 2003-06, Vol.14 (6), p.946-957 [Periódico revisado por pares]

Oxford: Oxford University Press

Texto completo disponível

Citações Citado por
6
Guidance on the use of bisphosphonates in solid tumours: recommendations of an international expert panel
Guidance on the use of bisphosphonates in solid tumours: recommendations of an international expert panel
Material Type:
Artigo 		Adicionar ao Meu Espaço

Guidance on the use of bisphosphonates in solid tumours: recommendations of an international expert panel

Aapro, M. ; Abrahamsson, P.A. ; Body, J.J. ; Coleman, R.E. ; Colomer, R. ; Costa, L. ; Crinò, L. ; Dirix, L. ; Gnant, M. ; Gralow, J. ; Hadji, P. ; Hortobagyi, G.N. ; Jonat, W. ; Lipton, A. ; Monnier, A. ; Paterson, A.H.G. ; Rizzoli, R. ; Saad, F. ; Thürlimann, B.

Annals of oncology, 2008-03, Vol.19 (3), p.420-432 [Periódico revisado por pares]

Oxford: Elsevier Ltd

Texto completo disponível

Citações Citado por
7
Guidelines for time-to-event end point definitions in breast cancer trials: results of the DATECAN initiative (Definition for the Assessment of Time-to-event Endpoints in CANcer trials)
Guidelines for time-to-event end point definitions in breast cancer trials: results of the DATECAN initiative (Definition for the Assessment of Time-to-event Endpoints in CANcer trials)
Material Type:
Artigo 		Adicionar ao Meu Espaço

Guidelines for time-to-event end point definitions in breast cancer trials: results of the DATECAN initiative (Definition for the Assessment of Time-to-event Endpoints in CANcer trials)

Gourgou-Bourgade, S. ; Cameron, D. ; Poortmans, P. ; Asselain, B. ; Azria, D. ; Cardoso, F. ; A'Hern, R. ; Bliss, J. ; Bogaerts, J. ; Bonnefoi, H. ; Brain, E. ; Cardoso, M.J. ; Chibaudel, B. ; Coleman, R. ; Cufer, T. ; Dal Lago, L. ; Dalenc, F. ; De Azambuja, E. ; Debled, M. ; Delaloge, S. ; Filleron, T. ; Gligorov, J. ; Gutowski, M. ; Jacot, W. ; Kirkove, C. ; MacGrogan, G. ; Michiels, S. ; Negreiros, I. ; Offersen, B.V. ; Penault Llorca, F. ; Pruneri, G. ; Roche, H. ; Russell, N.S. ; Schmitt, F. ; Servent, V. ; Thürlimann, B. ; Untch, M. ; van der Hage, J.A. ; van Tienhoven, G. ; Wildiers, H. ; Yarnold, J. ; Bonnetain, F. ; Mathoulin-Pélissier, S. ; Bellera, C. ; Dabakuyo-Yonli, T.S.

Annals of oncology, 2015-05, Vol.26 (5), p.873-879 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.